Fatal hepatic failure due to gemcitabine and vinorelbine [2]

Annals of Oncology

Volumn 14, Issue 6, 2003, Pages 960-

  Kagohashi, K ^a   Funyama, Y ^a   Satoh, Hiro ^a   Sekizawa, K ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; NAVELBINE;

ADULT; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG FATALITY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; INOPERABLE CANCER; LARYNX CARCINOMA; LETTER; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; TREATMENT OUTCOME; X RAY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; DEOXYCYTIDINE; FATAL OUTCOME; HUMANS; LIVER FAILURE, ACUTE; LUNG NEOPLASMS; MALE; MIDDLE AGED; VINBLASTINE;

EID: 0038688094     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdg239     Document Type: Letter

References (5)

1. Lilenbaum R, Cano R, Schwartz M et al. Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: a phase II study. Cancer 2000; 88: 557-562.
2. Lorusso V, Carpagnano F, Frasci G et al. Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer. J Clin Oncol 2000; 18: 405-411.
3. Gridelli C, Cigolari S, Gallo C et al. Activity and toxicity of gemcitabine and gemcitabine + vinorelbine in advanced non-small-cell lung cancer elderly patients: phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial. Lung Cancer 2001; 31: 277-284.
4. Dobbie M, Hofer S, Oberholzer M, Herrmann R. Veno-occulusive disease of the liver induced by gemcitabine. Ann Oncol 1998; 9: 681.
5. Coeman DC, Verbeken EK, Nackaerts KL et al. A fetal case of chelestatic liver failure probably related to gemcitabine. Ann Oncol 2000; 11: 1503.